DossierENTITY

Phase 3

Coverage of Phase 3 in the Nexus archive.

Earliest in view: Jul 8 · 14:20 UTCMost recent: Jul 8 · 14:20 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 8 · 14:20 UTCQUARTZ
Kailera's oral weight loss pill met its trial goal, but nausea hit 70% of patients
Kailera's oral weight loss pill HRS-7535 met its trial goal in Phase 3, but 70% of patients experienced nausea. The company's stock dropped 10% following the data release.